Bleeding disorders are a group of conditions that affect the body’s ability to form blood clots properly. Normally, when a person is injured, platelets and clotting proteins work together to stop bleeding. Some bleeding disorders are…
As we return from an energizing week at SCOPE 2026 in Orlando, one thing is clear: the industry conversation has evolved. The focus has shifted from experimentation to execution — from “Should we modernize?” to “How…
Clinical trials are becoming increasingly global. Studies now run across countries, involve participants from different cultures, and collect data from multiple healthcare systems. In principle, this should support broader representation and stronger evidence. But in practice,…
Rare Disease Day is observed every year on the last day of February. In the United States, a disease is considered rare (or orphan) when it affects fewer than 200,000 people. While each condition may impact…
In the United States alone, an estimated 6.7 million adults over the age of 20 are living with heart failure, and approximately 805,000 people experience a heart attack each year—about one every 40 seconds. American Heart…
The 17th Annual SCOPE Summit once again brought together leaders across clinical operations, digital health, patient engagement, and data innovation to shape the future of clinical research. This year, the tone was clear: the industry is…
Each year, nearly 20 million people worldwide are diagnosed with cancer, a number projected to rise sharply in the coming decades. For patients and families, a diagnosis often brings uncertainty, difficult treatment decisions, and limited options—particularly…
